Literature DB >> 10705399

Pleomorphic hyalinizing angiectatic tumor of soft parts: immunohistochemical study including the expression of vascular endothelial growth factor.

G M Groisman1, J Bejar, M Amar, O Ben-Izhak.   

Abstract

We report morphologic, flow cytometric, and immunohistochemical findings in two cases of pleomorphic hyalinizing angiectatic tumor of soft parts. Both patients were middle-aged women with subcutaneous lesions located in the lower extremity. The tumors consisted of sheets of spindled and pleomorphic cells with frequent intranuclear pseudoinclusions associated with clusters of ectatic vessels surrounded by prominent perivascular hyaline material. Numerous, nonhyalinized vessels were also present, mostly in the peripheral areas of the lesions. Some of these vessels had their walls permeated by numerous small capillaries. Immunostaining for vascular endothelial growth factor (VEGF), a secreted protein that has been implicated in tumor-associated angiogenesis, demonstrated positive staining in both tumoral and endothelial cells. Tumor cells were also reactive to vimentin and CD34. Focal positivity for CD99 and factor XIIIa was also present. Flow cytometry yielded a diploid DNA histogram with S-phase fraction of 7%. Our findings corroborate those from previously reported cases. They further suggest that angiogenesis and the angiogenic factor VEGF may play a role in the development of this peculiar tumor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10705399     DOI: 10.5858/2000-124-0423-PHATOS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  10 in total

1.  Pleomorphic hyalinizing angiectatic tumor: imaging findings.

Authors:  Ty K Subhawong; Andrea P Subhawong; Elizabeth A Montgomery; Laura M Fayad
Journal:  Skeletal Radiol       Date:  2012-06-03       Impact factor: 2.199

2.  An Unusual Soft Tissue Tumor of Uncertain Differentiation: a Case Report.

Authors:  Sawan Kumar; Amrita Talwar; Arvind Ahuja; Minakshi Bhardwaj
Journal:  Indian J Surg Oncol       Date:  2020-08-29

3.  Treatment modalities and outcomes of pleomorphic hyalinizing angiectatic tumor: a systematic review of the literature.

Authors:  A J Rush; P D Patel; S Shemesh; T K Subhawong; J Pretell-Mazzini
Journal:  Musculoskelet Surg       Date:  2018-02-01

4.  A subcutaneous pleomorphic hyalinizing angiectatic tumor of soft parts of the right chest wall: report of a rare case.

Authors:  Chuifeng Fan; Xuyong Lin; Lianhe Yang; Enhua Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  Pleomorphic Hyalinizing Angiectatic Tumour: A Rare Case Report and Discussion of Differential Diagnosis.

Authors:  Ambica Chalmeti; Surekha U Arakeri; Anita P Javalgi; Shefali Goyal
Journal:  J Clin Diagn Res       Date:  2017-08-01

Review 6.  Pleomorphic Hyalinizing Angiectatic Tumor (PHAT): Review of the Literature with Case Presentation.

Authors:  Gerardo Cazzato; Anna Colagrande; Antonietta Cimmino; Teresa Lettini; Maria Teresa Savino; Carmen Martella; Giuseppe Ingravallo; Leonardo Resta
Journal:  Dermatopathology (Basel)       Date:  2021-04-04

Review 7.  Hyalinization as a histomorphological risk predictor in oral pathological lesions.

Authors:  Dominic Augustine; Roopa S Rao; Shankargouda Patil
Journal:  J Oral Biol Craniofac Res       Date:  2021-05-20

8.  Pleomorphic hyalinizing angiectatic tumor arising in the groin: A case report.

Authors:  Chibueze Onyemkpa; Tolutope Oyasiji
Journal:  Int J Surg Case Rep       Date:  2016-10-08

Review 9.  Pleomorphic hyalinizing angiectatic tumor of the vulva: literature review based on a rare presentation.

Authors:  Eveline Cristina da Silva; Rodrigo Fonseca Abreu; Antônio Geraldo Nascimento; Louise De Brot Andrade
Journal:  Autops Case Rep       Date:  2022-02-11

10.  Imaging and histological appearance of pleomorphic hyalinizing angiectatic tumors: A case series and literature review.

Authors:  Couger Jimenez Jaramillo; John Wojcik; Kristy Weber; Ronnie Sebro
Journal:  Oncol Lett       Date:  2018-02-02       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.